Skip to main content
Content for healthcare professionals only
Radcliffe Group
Cardiology
Vascular
CVRM
Medical Education
Register for FREE
Log In
View all Platforms
CVRM
Topics
Content Type
Videos
Articles
Broadcasts
Education
Podcasts
News
Faculty
Events
Upcoming Events
Radcliffe Events
All Events
Radcliffe Platforms
Radcliffe Group
Cardiology
Vascular
CVRM
Medical Education
Register for FREE
Log In
Content for healthcare professionals only
Topics
Cardiomyopathy
Imaging and Diagnosis
Content Type
Videos
Articles
Broadcasts
Education
Podcasts
News
Faculty
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
View All
Events
Upcoming Events
Radcliffe Events
All Events
Breadcrumb
Home /
News Index
Latest News
External news
Written by:
Cardiovascular Business
FDA approves new pulmonary artery sensor for heart failure
24 June 2024
Written by:
Cardiovascular Business
Semaglutide improves heart failure symptoms in both sexes—weight loss greater in women
24 June 2024
Written by:
Drugs.com - Pharma Industry News
Hospital Nursing Resources Tied to COVID-19 Survival
24 June 2024
Written by:
Cardiology Today
Many older adults still use aspirin for CVD prevention, contrary to clinical guidance
24 June 2024
Written by:
Drugs.com - Pharma Industry News
Childhood Risk Factors Directly Tied to Adult Cardiovascular Disease
24 June 2024
Written by:
Drugs.com - Pharma Industry News
Medically Advised Aspirin Use Lower in 2021 Than 2012 to 2017
24 June 2024
Written by:
Drugs.com - Pharma Industry News
FDA Expands Approval for Duchenne Muscular Dystrophy Gene Therapy
24 June 2024
Written by:
Cardiology Today
First generic GLP-1 receptor agonist launched
24 June 2024
Written by:
Cardiac Vascular News
Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD)
24 June 2024
Written by:
Cardiac Vascular News
Alnylam Reports Positive Topline Results from HELIOS-B Phase 3 Study of Vutrisiran, Achieving Statistical Significance on Primary and All Secondary Endpoints in Both Overall and Monotherapy Populations
24 June 2024
Load More